RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Essex Bio-Technology Stock

Essex Bio-Technology ROA 2024

Essex Bio-Technology ROA

0.1

Ticker

1061.HK

ISIN

KYG312371035

WKN

693609

In 2024, Essex Bio-Technology's return on assets (ROA) was 0.1, a 17.14% increase from the 0.08 ROA in the previous year.

Essex Bio-Technology Aktienanalyse

What does Essex Bio-Technology do?

Essex Bio-Technology Ltd is a biotechnology company that was founded in Essex, England in 1999. The company specializes in the research and development of innovative products in the healthcare sector, with a focus on the development of vaccines for globally prevalent diseases. Over the years, Essex Bio-Technology Ltd has evolved into a global company operating in Europe, Asia, Africa, and North America. It has offices in the UK, Canada, and China. The company is dedicated to improving the health and well-being of people worldwide, utilizing cutting-edge technology and scientific innovations. Its business model is based on the research, development, and marketing of biotechnology products for the pharmaceutical industry. One of the key areas of focus for Essex Bio-Technology Ltd is the discovery and development of vaccines. The company has made significant progress in particular in the development of vaccines for influenza and tuberculosis. It has also collaborated with other companies in the development of a vaccine for COVID-19. In addition to vaccines, Essex Bio-Technology Ltd has also developed products for medical diagnostics and cancer immunotherapy. These products are used in medical practice and have proven to be extremely successful. Overall, Essex Bio-Technology Ltd has developed an impressive range of products that cover important areas of healthcare. The products are of the highest quality and meet the highest standards in the biotechnology industry. In recent years, the company has established a strong partnership with the pharmaceutical industry. It has conducted collaborative research projects with some of the largest companies in the field to develop new biotechnology products. It has also played a central role in collaboration with governments and non-profit organizations worldwide to ensure that critical medical needs are met. Essex Bio-Technology Ltd stands for the highest quality standards and a commitment to improving healthcare. The company is a leader in biotechnological research and development and has made a name for itself in the pharmaceutical industry. It is a company to be proud of and one that is at the forefront of the journey towards better healthcare for all worldwide. Essex Bio-Technology ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Essex Bio-Technology's Return on Assets (ROA)

Essex Bio-Technology's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Essex Bio-Technology's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Essex Bio-Technology's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Essex Bio-Technology’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Essex Bio-Technology stock

What is the Return on Assets (ROA) of Essex Bio-Technology this year?

The Return on Assets (ROA) of Essex Bio-Technology is 0.1 undefined this year.

What was the ROA of Essex Bio-Technology compared to the previous year?

The ROA of Essex Bio-Technology has increased by 17.14% compared to the previous year.

What consequences do high ROA have for investors of Essex Bio-Technology?

A high ROA is advantageous for investors of Essex Bio-Technology, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Essex Bio-Technology?

A low ROA can be unfavorable for investors of Essex Bio-Technology as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Essex Bio-Technology affect the company?

An increase in ROA of Essex Bio-Technology can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Essex Bio-Technology impact the company?

A reduction in the ROA of Essex Bio-Technology can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Essex Bio-Technology?

Some factors that can influence the ROA of Essex Bio-Technology include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Essex Bio-Technology important for investors?

The ROA of Essex Bio-Technology is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Essex Bio-Technology take to improve ROA?

To improve ROA, Essex Bio-Technology can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Essex Bio-Technology pay?

Over the past 12 months, Essex Bio-Technology paid a dividend of 0.07 HKD . This corresponds to a dividend yield of about 2.41 %. For the coming 12 months, Essex Bio-Technology is expected to pay a dividend of 0.08 HKD.

What is the dividend yield of Essex Bio-Technology?

The current dividend yield of Essex Bio-Technology is 2.41 %.

When does Essex Bio-Technology pay dividends?

Essex Bio-Technology pays a quarterly dividend. This is distributed in the months of July, September, June, October.

How secure is the dividend of Essex Bio-Technology?

Essex Bio-Technology paid dividends every year for the past 0 years.

What is the dividend of Essex Bio-Technology?

For the upcoming 12 months, dividends amounting to 0.08 HKD are expected. This corresponds to a dividend yield of 2.66 %.

In which sector is Essex Bio-Technology located?

Essex Bio-Technology is assigned to the 'Health' sector.

Wann musste ich die Aktien von Essex Bio-Technology kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Essex Bio-Technology from 9/24/2024 amounting to 0.06 HKD, you needed to have the stock in your portfolio before the ex-date on 9/6/2024.

When did Essex Bio-Technology pay the last dividend?

The last dividend was paid out on 9/24/2024.

What was the dividend of Essex Bio-Technology in the year 2023?

In the year 2023, Essex Bio-Technology distributed 0.095 HKD as dividends.

In which currency does Essex Bio-Technology pay out the dividend?

The dividends of Essex Bio-Technology are distributed in HKD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Essex Bio-Technology

Our stock analysis for Essex Bio-Technology Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Essex Bio-Technology Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.